Evidence map›Paper›PMID 27489378›Full record

ArticleClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2016

Association of Polymorphisms within the Serotonin Receptor Genes 5-HTR1A, 5-HTR1B, 5-HTR2A and 5-HTR2C and Migraine Susceptibility in a Turkish Population.

Yavuz Yücel, Salih Coşkun, Beyhan Cengiz, Hasan H Özdemir, Ertuğrul Uzar, Abdullah Çim, M Akif Camkurt, M Ufuk Aluclu

Open access · diamondAbstract read
In one paragraph

Article in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Exploring the pharmacological action mechanism ofFrontiers in pharmacology · 2022
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Antidepressants for Preventive Treatment of Migraine.Current treatment options in neurology · 2019
    Review
  15. Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2018
    Review
  16. Development of an AmpliSeqFrontiers in pharmacology · 2018
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yavuz YücelDepartment of Neurology, Dicle University, Medical Faculty, Diyarbakır, Turkey.
Salih CoşkunDepartment of Medical Genetics, Dicle University, Medical Faculty, Diyarbakır, Turkey.
Beyhan CengizDepartment of Medical Genetics, Medical Faculty, Gazi University, Ankara, Turkey.
Hasan H ÖzdemirDepartment of Neurology, Dicle University, Medical Faculty, Diyarbakır, Turkey.
Ertuğrul UzarDepartment of Neurology, Dicle University, Medical Faculty, Diyarbakır, Turkey.
Abdullah ÇimDepartment of Medical Genetics, Dicle University, Medical Faculty, Diyarbakır, Turkey.
M Akif CamkurtDepartment of Psychiatry, Afsin State Hospital, Kahramanmaras, Turkey.
M Ufuk AlucluDepartment of Neurology, Dicle University, Medical Faculty, Diyarbakır, Turkey.
Dicle University · TRGazi University · TRKahramanmaraş Sütçü İmam University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMigraine, a highly prevelant headache disorder, is regarded as a polygenic multifactorial disease. Serotonin (5-HT) and their respective receptors have been implicated in the patogenesis.

methodsWe investigated the 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor gene polymorphisms and their association with migraine in Turkish patients. The rs6295, rs1300060, rs1228814, rs6311, rs6313, rs6314, rs6318, rs3813929 (-759C/T) and rs518147 polymorphisms were analyzed in 135 patients with migraine and 139 healthy subjects, using a BioMark 96.96 dynamic array system.

resultsWe found no difference in the frequency of the analyzed eight out of nine polymorpisms between migraine and control groups. However, a significant association was found between the rs3813929 polymorphism in the promoter region of 5-HTR2C gene and migraine. Also, the allele of rs3813929 was more common in the migraine group.

conclusionThis result suggests that the 5-HTR2C rs3813929 polymorphism can be a genetic risk factor for migraine in a Turkish population.

Indexed as

5-HT2CGenetic association studiesHeadacheMigraine disordersReceptorserotoninSingle nucleotide polymorphism

Identifiers

PMID27489378
PMCPMC4977812
OpenAlexW2496810827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.